Kurt Sundermann is a notable inventor based in Summerfield, NC (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target RAGE-mediated diseases. With a total of 3 patents to his name, Sundermann's work is paving the way for new therapeutic options.

Latest Patents

Sundermann's latest patents include innovative phenyl-heteroaryl derivatives and methods of use thereof. These compounds, represented by Formula (I), are designed to be pharmaceutically acceptable salts that are useful in treating RAGE-mediated diseases, including Alzheimer's Disease. The patents also detail methods for the preparation of these compounds, pharmaceutical compositions that include them, and their application in treating such diseases.

Career Highlights

Throughout his career, Sundermann has worked with prominent companies in the pharmaceutical industry, including Transtech Pharma, Inc. and VTV Therapeutics LLC. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of Sundermann's notable coworkers include Devi Reddy Gohimukkula and David R. Jones. Their collaborative efforts have further enhanced the impact of his inventions in the pharmaceutical sector.

Conclusion

Kurt Sundermann's innovative work in pharmaceutical chemistry exemplifies the importance of research and development in addressing critical health issues. His contributions continue to influence the treatment of RAGE-mediated diseases, showcasing the potential of his inventions in improving patient outcomes.

Profile summary based on public USPTO records.